Improved Overall Survival in Pancreatic Cancer with Preoperative Chemoradiotherapy: Long-term Results of the PREOPANC Trial

HPB2.90
Volume: 23, Pages: S672 - S673
Published: Jan 1, 2021
Abstract
Purpose: The PREOPANC trial suggested a benefit of preoperative chemoradiotherapy in patients with resectable (RPC) and borderline resectable pancreatic cancer (BRPC). Long-term results are presented. Methods: In this Dutch multicenter phase III trial, patients with RPC or BRPC were included. Patients were randomized to either preoperative chemoradiotherapy (three cycles of full dose gemcitabine 1000 mg/m2 weekly, the second combined with 15...
Paper Details
Title
Improved Overall Survival in Pancreatic Cancer with Preoperative Chemoradiotherapy: Long-term Results of the PREOPANC Trial
Published Date
Jan 1, 2021
Journal
Volume
23
Pages
S672 - S673
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.